cjc 1295 with dac vs ipamorelin CJC-1295 No & – San Jose Peptides (ARL) Ipamorelin vs CJC 1295 |

Metabolite detection studies have identified specific degradation products of ipamorelin and other GHRPs in urine after nasal and subcutaneous administration, which has enabled anti-doping laboratories to detect their use

FDA Approved CJC-1295/Ipamorelin No Tesamorelin (Egrifta) Yes (November 2010) Mechanism CJC-1295/Ipamorelin GHRH analog + ghrelin receptor agonist (dual pathway) Tesamorelin (Egrifta) GHRH analog (single pathway) How It Works CJC-1295/Ipamorelin CJC-1295 extends GH release signal

Bioeng Transl Med

It is then translocated to the cell nucleus where it interacts with the retinoid X receptor and nuclear receptor 77 to form a complex that can regulate transcription and can induce apoptosis (12, 13) (Fig

Nightly micro-injections coax the pituitary to release pulses of GH, reinforcing the bodys own circadian rhythm and improving sleep architecture